Clinician resources for heart health

Discover how clinicians incorporate markers of cardiac dysfunction, vascular inflammation and dysfunction, dyslipidemia, and cardiometabolic status into their practice to effectively manage chronic diseases and improve overall cardiovascular health.

Technology Video Singulex High-Definition Immunoassay Technology
Vascular Inflammation and Dysfunction (Inflammation) Singulex Cytokines: IL-6, IL-17A, TNF-α
Category Title Biomarker Disease Focus Speaker
Cardiac Dysfunction High Definition Cardiac Troponin I (cTnI) in The Chronic Disease Setting cTnI Dr. Matthew Budoff, MD, FACC, FAHA Professor of Medicine Director, Cardiac CT Harbor-UCLA Medical Center, Torrance, CA
Cardiac Dysfunction Establishing Clinically Relevant Biomarkers Through Advanced Single Molecule Counting cTnI Dr. Cleland C. Landolt, MD, FACS, FACC, FACP Medical Advisor, Singulex, Inc.
Cardiac Dysfunction Applications for High Sensitivity Protein Assays cTnI Alan H.B. Wu, PhD Professor Laboratory Medicine, UCSF Chief, Clinical Chemistry Laboratory, San Francisco General Hospital
Across all functions Overview on Singulex Cardiovascular Advanced testing & Personalized Wellness Program. Watch the 4-part video series on YouTube:
Part 1: Benefits and Opportunity
Part 2: SMCTM cTnI test
Part 3: Advanced Lipid Menu
Part 4: CVMedHome Wellness Program
cTnI; Lipids Dr. Nate Lebowitz, MD, FACC Advanced Cardiology Institute

Information herein pertains to testing performed by or for the Singulex Clinical Laboratory. Singulex proprietary lab developed tests (SMC™ tests, sd-LDL, HDL2b, Adiponectin and Leptin) were developed and performance characteristics were determined by Singulex. These tests have not been cleared or approved by the U.S. Food and Drug Administration.